Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong

Chinese Medical Journal

Volumn 112, Issue 8, 1999, Pages 754-757

  Law, Lapkay ^a   Lau, Tzekin ^a   Fung, Takyuen ^a   Rogers, Michael S ^a   Hjelm, Magnus ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alpha fetoprotein; Down syndrome; Screening; Total hCG

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AMNIOCENTESIS; ARTICLE; BLOOD; DOWN SYNDROME; ECHOGRAPHY; FEMALE; HONG KONG; HUMAN; KARYOTYPING; METABOLISM; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY;

ADULT; ALPHA-FETOPROTEINS; AMNIOCENTESIS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; HONG KONG; HUMANS; KARYOTYPING; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 0040886247     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hsu JJ, HsieH TST, Hsieh FJ. Down syndrome screening in an Asian population using alpha-Fetoprotein and free β-hCG: a report of the Taiwan Down syndrome screening sroup. Obstet Gynecol 1996; 87:943-947.
2. Lau TK, Fung HYM, Rogers MS, et al. Racial variations in incidence of trisomy 21. Am J Med Genet 1998;75:386-388.
3. Palomaki GE, Knight GJ, Holman MS, et al. Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey. Am J Obstet Gynecol 1990;162:317-321.
4. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-630.
5. Petrocik E, Wassman ER, Kelly JC. Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels. Am J Obstet Gynecol 1989;161:1168-1173.
6. White I, Papiha SS, Magnay D. Improving methods of screening for Down's syndrome. N Engl J Med 1989;320:401-402.
7. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-593.
8. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297: 833-837.
9. Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: differences between races or ethnic groups. Clin Chem 1997;43:333-337.
10. Bogart MH, Jones OW, Felder RA, et al. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991;165:663-667.
11. Crandall BF, Lebher TB, Schroth PC, et al. Alpha-fetoprotein concentrations in maternal serum: relation to! race and body weight. Clin Chem 1983;29:531-533.
12. Johnson AM. Racial differences in maternal serum alpha-fetoprotein screening. In: Mizejewski GJ, Porter IH, eds. Alpha-fetoprotein and congenital disorders. New York: Academic Press, 1985: 183-196.
13. Simpson JL, Elias S, Morgan CD, et al. Second trimester maternal serum human chorionic gonadotropin and unconjugated oestriol levels in blacks and whites. Lancet 1990;335:459-460.
14. Canick JA, Panizza DS, Palomaki GE. Prenatal screening for Down syndrome using APP, uE3 and hCG: effect of maternal race, insulin-dependent diabetes and twin pregnancy. Am J Hum Genet 1990;47:A270.
15. Hsu JJ, Hsieh TT, Lo LM, et al. Midtrimester human chorionic gonadotropin levels: normal reference values in Chinese pregnant women. Chang Gung Med J 1995;18:240-247.
16. Hsu JJ, Chiu TH, Chen KC, et al. Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation. Chang Gung Med J 1994;17:309-315.
17. O'Brien JE, Drugan A, Chervenak FA, et al. Maternal serum alpha-fetoprotein screening: The need to use race/ethnic specific medians in Asias. Fetal Diagn Ther 1993;8:367-370.
18. Wald NF, Cuckle HS. Biochemical Screening. In: Brock JH, Rodeck CH, Ferguson-Smith MA), eds. Prenatal diagnosis and screening. London: Churchill Livingstone, 1992;563-571.
19. Sailer DN Jr, Canick JA, Schwartz S, et al. Multiple marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. Am J Obstet Gynecol 1992;167:1021-1024.
20. Palomaki GE, Knight GJ, Haddow JE, et al. Prospective intervention trial of a screening protocol to identify fetal trisomay 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn 1992;120:925-930.